Metraipolis › archive › dc_74b7ea94b645
Measurement of Novel, Drinking Water-Associated PFAS in Blood from Adults and Children in Wilmington, North Carolina — Europe PMC PMID:32697103
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32697103
- DOI
- 10.1289/ehp6837
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T01:43:40.175Z
- SHA-256 of the archived text
2e7a218f627cc12c5c83d102097e005addf54fdfa871c5eaec8bdeda018f1f39- Stable URL of this page
https://metraipolis.com/documento/dc_74b7ea94b645
How to cite
Measurement of Novel, Drinking Water-Associated PFAS in Blood from Adults and Children in Wilmington, North Carolina — Europe PMC PMID:32697103 — Europe PMC (en), https://europepmc.org/article/MED/32697103 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_74b7ea94b645 (Metraipolis archive dc_74b7ea94b645, sha256 2e7a218f627cc12c5c83d102097e005addf54fdfa871c5eaec8bdeda018f1f39)
BibTeX
@misc{dc74b7ea94b645,
title = {Measurement of Novel, Drinking Water-Associated PFAS in Blood from Adults and Children in Wilmington, North Carolina — Europe PMC PMID:32697103},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32697103},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_74b7ea94b645; sha256 2e7a218f627cc12c5c83d102097e005addf54fdfa871c5eaec8bdeda018f1f39},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32697103. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: From 1980 to 2017, a fluorochemical manufacturing facility discharged wastewater containing poorly understood per- and polyfluoroalkyl substances (PFAS) to the Cape Fear River, the primary drinking water source for Wilmington, North Carolina, residents. Those PFAS included several fluoroethers including HFPO-DA also known as GenX. Little is known about the bioaccumulation potential of these fluoroethers. Objective: We determined levels of fluoroethers and legacy PFAS in serum samples from Wilmington residents. Methods: In November 2017 and May 2018, we enrolled 344 Wilmington residents ≥6 years of age into the GenX Exposure Study and collected blood samples. Repeated blood samples were collected from 44 participants 6 months after enrollment. We analyzed serum for 10 fluoroethers and 10 legacy PFAS using liquid chromatography-high-resolution mass spectrometry. Results: Participants' ages ranged from 6 to 86 y, and they lived in the lower Cape Fear Region for 20 y on average (standard deviation: 16 y). Six fluoroethers were detected in serum; Nafion by-product 2, PFO4DA, and PFO5DoA were detected in >85% of participants. PFO3OA and NVHOS were infrequently detected. Hydro-EVE was present in a subset of samples, but we could not quantify it. GenX was not detected above our analytical method reporting limit (2 ng/mL). In participants with repeated samples, the median decrease in fluoroether levels ranged from 28% for PFO5DoA to 65% for PFO4DA in 6 months due to wastewater discharge control. Four legacy PFAS (PFHxS, PFOA, PFOS, PFNA) were detected in most (≥97%) participants; these levels were higher than U.S. national levels for the 2015-2016 National Health and Nutrition Examination Survey. The sum concentration of fluoroethers contributed 24% to participants' total serum PFAS (median: 25.3 ng/mL). Conclusion: Poorly understood fluoroethers released into the Cape Fear River by a fluorochemical manufacturing facility were detected in blood samples from Wilmington, North Carolina, residents. Health implications of exposure to these novel PFAS have not been well characterized. https://doi.org/10.1289/EHP6837. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2020 (prima pubblicazione 2020-07-22). Identificativi: PMID 32697103 · PMCID PMC7375159 · DOI 10.1289/ehp6837. Pagina: https://europepmc.org/article/MED/32697103 — https://doi.org/10.1289/ehp6837. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T01:39:52.742Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.